Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 907

1.

Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service.

Ahmed AA, Alsharief E, Alsharief A.

Diabetes Metab Syndr. 2013 Jul-Sep;7(3):133-7. doi: 10.1016/j.dsx.2013.06.012. Epub 2013 Jul 17.

PMID:
23953177
2.

Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.

Al-Omran M.

Vasc Health Risk Manag. 2012;8:349-55. doi: 10.2147/VHRM.S32783. Epub 2012 May 28.

3.

Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.

Agarwal AK, Singh M, Arya V, Garg U, Singh VP, Jain V.

J Assoc Physicians India. 2012 Jul;60:28-32.

PMID:
23405538
5.

Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.

Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A; SFIDA Study Group--Italian Association of Diabetologists (AMD).

Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):204-11.

PMID:
15955469
6.

Risk factor control for coronary artery disease secondary prevention in large randomized trials.

Farkouh ME, Boden WE, Bittner V, Muratov V, Hartigan P, Ogdie M, Bertolet M, Mathewkutty S, Teo K, Maron DJ, Sethi SS, Domanski M, Frye RL, Fuster V.

J Am Coll Cardiol. 2013 Apr 16;61(15):1607-15. doi: 10.1016/j.jacc.2013.01.044.

7.

Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008.

Fhärm E, Cederholm J, Eliasson B, Gudbjörnsdottir S, Rolandsson O.

Diabet Med. 2012 Feb;29(2):198-206. doi: 10.1111/j.1464-5491.2011.03425.x.

PMID:
21883434
8.
9.

Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.

Thomas G, Khunti K, Curcin V, Molokhia M, Millett C, Majeed A, Paul S.

Diabetes Obes Metab. 2014 Apr;16(4):317-25. doi: 10.1111/dom.12217. Epub 2013 Oct 29.

PMID:
24118783
10.

Management outcomes of patients with type 2 diabetes: targeting the 10-year absolute risk of coronary heart disease.

Yong TY, Phillipov G, Phillips PJ.

Med J Aust. 2007 Jun 18;186(12):622-4. Erratum in: Med J Aust. 2007 Aug;187(3):152.

PMID:
17576176
11.

Sex- and BMI-related differences in risk factors for coronary artery disease in patients with type 2 diabetes mellitus.

Bo S, Gentile L, Cavallo-Perin P, Vineis P, Ghia V.

Acta Diabetol. 1999 Sep;36(3):147-53.

PMID:
10664319
12.

Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.

Charpentier G, Genès N, Vaur L, Amar J, Clerson P, Cambou JP, Guéret P; ESPOIR Diabetes Study Investigators.

Diabetes Metab. 2003 Apr;29(2 Pt 1):152-8.

PMID:
12746636
13.

Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.

Abdu TA, Neary R, Elhadd TA, Akber M, Clayton RN.

Clin Endocrinol (Oxf). 2001 Aug;55(2):209-16. Erratum in: Clin Endocrinol (Oxf) 2001 Nov;55(5):699.

PMID:
11531927
14.

Coronary artery disease, microalbuminuria and lipid profile in patients with non-insulin dependent diabetes mellitus.

Bahia L, Gomes MB, da Cruz P di M, Gonçalves Mde F.

Arq Bras Cardiol. 1999 Jul;73(1):11-22. English, Portuguese.

PMID:
10684138
15.

Control to goal of cardiometabolic risk factors among Nigerians living with type 2 diabetes mellitus.

Okafor CI, Ofoegbu EN.

Niger J Clin Pract. 2012 Jan-Mar;15(1):15-8. doi: 10.4103/1119-3077.94089.

16.

New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study.

Ledru F, Ducimetière P, Battaglia S, Courbon D, Beverelli F, Guize L, Guermonprez JL, Diébold B.

J Am Coll Cardiol. 2001 May;37(6):1543-50.

17.

Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.

Hermans MP, Brotons C, Elisaf M, Michel G, Muls E, Nobels F; (for the OPTIMISE (OPtimal Type 2 dIabetes Management Including benchmarking and Standard trEatment) International Steering Committee).

Eur J Prev Cardiol. 2013 Dec;20(6):1095-105. doi: 10.1177/2047487312449414. Epub 2012 May 17.

PMID:
22605788
18.

Supplemental Content

Support Center